OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
28/02/2025
Voltar para busca
Dado oficial do USPTO
MAMMATYPER
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
28/02/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10, 42, 44
Data de depósito
07/11/2022
Data de registro
04/06/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
04/06/2024
Última transação
28/02/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
CN
Examinador
GILLES, DEBORAH
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
SHUWEN BIOTECH CO., LTD.
Representantes
Michael T. Smith Birch Stewart Kolasch & Birch LLP
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Diagnostic preparations for medical purposes relating to obstetrics or breast cancer; chemical reagents for medical purposes relating to obstetrics or breast cancer; diagnostic biomarker reagents for medical purposes; reagents for use in medical genetic testing; pharmaceutical drugs for the treatment of breast cancer; pharmaceutical preparations for the prevention and treatment of breast cancer; pharmaceutical products for the prevention and treatment of breast cancer; biological preparations for the treatment of breast cancer
Classe 10
Testing apparatus for medical purposes relating to obstetrics and breast cancer for detecting cancer; genetic testing apparatus for medical purposes; diagnostic apparatus for medical purposes relating to obstetrics and breast cancer; apparatus for use in medical analysis relating to obstetrics or breast cancer for detecting cancer; medical apparatus and instruments relating to obstetrics and breast cancer; apparatus for DNA and RNA testing for medical purposesX-ray diagnostic apparatus
Classe 42
Scientific research in the fields of obstetrics and breast cancer; scientific research on breast cancer for medical purposes; scientific research in the nature of conducting clinical trials for others in the fields of obstetrics and breast cancer; medical research in the fields of obstetrics and breast cancer; structural and functional analysis of genomes; research and development of pharmaceuticals of breast cancer; medical research in oncologybreast cancer; genetic testing for scientific research; technological research in the fields of obstetrics and breast cancer
Classe 44
Genetic testing for medical use; genetic testing for medical purposes; telemedicine services on medical testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical screening relating to obstetrics and breast cancer; rental of medical equipmentequipment relating to obstetrics and breast cancer; medical therapy services in the fields of obstetrics and breast cancer; medical analysis services for the diagnosis of breast cancer; provide breast cancer screening services
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/02/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/02/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/12/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
16/11/2024
FIMP
FINAL DISPOSITION PROCESSED
16/11/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/09/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/06/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
04/06/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19/03/2024
PUBO
PUBLISHED FOR OPPOSITION
19/03/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/02/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/02/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/01/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/01/2024
ATRV
ATTORNEY REVIEW COMPLETED
31/10/2023
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
30/10/2023
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
16/09/2023
RFNT
REFUSAL PROCESSED BY IB
01/08/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
13/07/2023
RFRR
REFUSAL PROCESSED BY MPU
13/07/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/06/2023
CNRT
NON-FINAL ACTION WRITTEN
05/06/2023
DOCK
ASSIGNED TO EXAMINER
27/05/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
25/03/2023
MAFR
APPLICATION FILING RECEIPT MAILED
04/03/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/02/2023
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
27/02/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
23/02/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MAMMATYPER ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.